Prevention of hepatitis C virus infection.
In spite of advances made in our understanding of the biology of the hepatitis C virus (HCV), the epidemiology and natural history of HCV infection, and the treatment of chronic hepatitis C, the development and worldwide implementation of a comprehensive prevention and control strategy remains necessary. A World Health Organization informal consultation with the Viral Hepatitis Prevention Board was convened and met in Geneva, Switzerland, 13-14 May 2002, to review epidemiological and public health aspects of HCV infection, and the various prevention and control strategies that are currently in place. Based on the presentations and discussions, a number of specific recommendations were made, which should be considered in conjunction with previously published recommendations.
Kew
M
M
South African Medical Research Council/Cancer Association of South Africa/University Molecular Hepatology Research Unit, Department of Medicine, University of the Witwatersrand, and Johannesburg Hospital, Johannesburg, South Africa.
François
G
G
Lavanchy
D
D
Margolis
H
H
Van Damme
P
P
Grob
P
P
Hallauer
J
J
Shouval
D
D
Leroux-Roels
G
G
Meheus
A
A
D000998:Antiviral Agents / Q000627:therapeutic use; D005260:Female; D006266:Health Education; D006526:Hepatitis C / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control* / Q000635:transmission; D006801:Humans; D008297:Male; D012309:Risk-Taking
D000998:Antiviral Agents